...
首页> 外文期刊>Journal of neurosurgical sciences >Prophylactic granisetron for post-spinal anesthesia shivering in cesarean section: A randomized controlled clinical study
【24h】

Prophylactic granisetron for post-spinal anesthesia shivering in cesarean section: A randomized controlled clinical study

机译:剖宫产术后脊髓麻醉后预防性格拉司琼:随机对照临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background The serotonergic system is known to be involved in control of post-anesthetic shivering. Our hypothesis was that prophylactic granisetrone (serotonin antagonist) might reduce incidence of post-spinal anesthesia shivering in cesarean section. Methods Parturient scheduled for elective cesarean delivery under spinal anesthesia were allocated to receive 0.9% saline (Group I, n = 71), 1 mg granisetron (Group II, n = 69), or 0.7 mg granisetron (Group III, n = 72) before the spinal block. Assessment parameters included; hemodynamics, tympanic membrane temperature, neonatal Apgar score, shivering score, patient satisfaction scores about shivering prophylaxis and adverse effects. Results Clinically significant shivering was recorded in 55/71 patients (77.5%) in group I, 11/69 (15.9%) in group II and 21/72 (29.2%) in group III (P = 0.000). The intensity of shivering was significantly lower in patients who received granisetron 1 mg compared with granisetron 0.7 mg or saline (P = 0.000). Patients who received prophylactic granisetron 1 mg reported lower mean intraoperative arterial pressure and heart rate values and consumed higher doses of iv ephedrine compared with 0.7 mg granisetron or saline placebo (P 0.05). Pruritus significantly decreased from (22.5%) in control group to (0%) in granisetron groups (P = 0.000). Nausea was reported in 8 vs 10 and four in group I, II and III, respectively (P 0.03). Sixteen vs eight and six patients vomited in group I, II, and III, respectively (P 0.03). Higher patient satisfaction scores were recorded in group II (9.83 +/- 0.29, P 0.03) and III (9.14 +/- 1.04, P 0.04), compared with control group (8.23 +/- 1.14). Conclusion Prophylactic granisetron effectively reduced incidence and severity of perioperative shivering in a dose dependent manner, compared to placebo controls.
机译:众所周知,血清奈奈能系统涉及对麻醉后颤动的控制。我们的假设是预防性格拉酮(血清素拮抗剂)可能会降低脊髓椎间椎间椎间盘麻醉发生率。方法分配脊髓麻醉下的选修剖面递送的份额分配为0.9%盐水(基团I,N = 71),1mg格拉司琼(II,N = 69),或0.7mg格兰司琼(III族,N = 72)在脊柱块之前。包括评估参数;血流动力学,鼓膜膜温度,新生儿APGAR评分,颤抖得分,患者满意度评分对颤动的预防和不良反应。结果临床显着的颤抖于III组第II族,11/69(15.9%),11/69(15.9%),III组的21/72(29.2%)(P = 0.000)。与Granisetron 0.7mg或盐水(P = 0.000)相比,接受Granisetron 1mg的患者,颤抖的强度显着降低。接受预防格兰司琼1mg的患者报告了较低的平均术中动脉压和心率值,并且与0.7mg格拉管或盐水安慰剂(P <0.05)相比,消耗较高剂量的IV麻黄碱(P <0.05)。瘙痒从对照组中的(22.5%)在格兰蛋白酶组中的(0%)显着降低(P = 0.000)。在I型,II和III组中,在8 vs 10和4中报道了恶心(P <0.03)。分别在I,II和III组中呕吐的六个和六个患者(P <0.03)。与对照组相比,II族(9.83 +/- 0.29,P&LT; 0.03)和III(9.14 +/- 1.04,P <0.04)中记录较高的患者满意度评分。结论预防性格兰司汀与安慰剂对照相比,预防性格兰司琼以依赖于剂量依赖性方式的发病率和严重程度降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号